Only connect (for cercival cancer)…

Here’s a story we covered earlier now in the Irish Times

The protest over the decision by Minister for Health Mary Harney to scrap the introduction of a cervical cancer vaccine programme for 12-year-old girls next year is due to take place at 2pm today on Dublin’s O’Connell Street. The rally has unusually been organised on the internet through a discussion group on the social networking site Facebook and the Feminist Open Forum. Shauneen Armstrong, who set up the Facebook group at lunchtime on Wednesday, said it already had 2,000 members.

We await the actual results. But if you do go along, you can upload your pics to the appropriate Flickr group and let us know… Or if you can’t be there, you might register support by joining the Facebook group here

  • Ri Na Deise

    Our Minister For Health is clinically obese.
    CLINICALLY OBESE! Only in fcukin Ireland!

  • James MacLochlainn

    At $120 a pop it is the most expensive injection in the world. Check this link to see it isnt even effective.

  • Health Canada on HPV:

    A vaccine, called Gardasil™, which prevents certain types of HPV has been approved for use in Canada. The vaccine protects against infection with two high risk types of HPV (16 and 18) and two low risk types (6 and 11). HPV types 16 and 18 cause approximately 70% of cervical cancers. HPV types 6 and 11 cause approximately 90% of ano-genital warts. The HPV vaccine appears to be very effective in preventing HPV infection and changes in the cell of the cervix related to these types of HPV.

  • susan

    Top man, Mark.

    My eldest daughter will be thirteen soon. She’s smart, sweet, and still so innocent I sometimes catch my breath, and she will receive the vaccines.

    How could I live with myself if later in her life she were diagnosed with a cancer that could cost her her life or her fertility, and I as her mother would know that there was a vaccine I could have given her that most likely could have prevented the illness, and I did not?

  • James MacLochlainn

    Gardasil, the vaccine from Merck against against two strains of the human papillomavirus, known as HPV 16 and 18, which has been marketed to save women and young children from cervical cancer is now being questioned by experts, according to a front page story in the Wall Street Journal.

    In clinical trials, Gardasil showed only a 14% lower rate of precancerous lesions within 3 years of vaccination when compared to a control group. “I do believe that Gardasil protects against HPV 16 and 18, but the effect it will have on cervical-cancer rates in this country is another question entirely,” says Dr. Scott Emerson, a professor of biostatistics at the University of Washington who sat on the FDA advisory committee, “There is a leap of faith involved

    The article details the length at which Merck has marketed the vaccine to become mandatory in states for young girls, although Merck only tested the vaccine in only a few hundred 11- and 12-year-old girls.

    Despite all of these questions, Merck has distributed more than four million doses of Gardasil in the U.S.